ClinicalTrials.Veeva

Menu

Neurogenic Inflammation in Peri-implant and Periodontal Diseases

O

Ondokuz Mayıs University

Status

Completed

Conditions

Periimplant Diseases
Periodontal Diseases
Periimplant Sulcular Fluid
Gingival Crevicular Fluid
Neurogenic Inflammation

Treatments

Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection

Study type

Observational

Funder types

Other

Identifiers

NCT03663140
OMU KAEK 2011/752

Details and patient eligibility

About

Regulatory effects of some neuropeptides substance-P (SP), neurokinin-A (NKA), calcitonin gene-linked peptide (CGRP) and neuropeptide-Y (NPY) )on inflammatory responses in periodontal disease has been described; however, the impact of neuropeptide levels are not clearly defined in healthy and diseased peri-implant tissues.ın order to evaluate the situation, thirty-nine implants that have been loaded over the past 12 months and their symmetrically matching teeth were evaluated using a split-mouth study design. Clinical periodontal examinations included the Silness-Löe plaque index, Löe-Silness gingival index, bleeding on probing, probing pocket depth and clinical attachment level parameters were determined. Gingival crevicular fluid (GCF)/Periimplant sulcular fluid (PISF) samples were collected, and the levels of the neuropeptides were determined by enzyme-linked immunosorbent assay. Correlations between GCF/PISF neuropeptide levels and the clinical examination parameters were evaluated in the peri-implant/periodontal soft tissues.

Enrollment

39 patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

The main inclusion criteria for patient selection were as follows:

  • Compliance with systematic maintenance care;
  • Adult, non-smoker, systemically healthy
  • Not using any medicament for the last 6 months ;
  • Partially dentated patient treated with implant-supported metal ceramic full crowns and/or fixed partial dentures
  • As the study was split-mouth designed, in each individual at least one implant and one matching tooth in the same mouth symmetrically representing the same tooth group (premolars/molars);
  • A single type of metal ceramic implant restoration that is functional for at least 1 year; and a matching tooth with no dental or endodontic restorations.

Exclusion criteria

  • Medical history of cancer, rheumatoid arthritis, diabetes mellitus, or cardiovascular disease and any other systemic disease affecting lipid metabolism (i.e. impaired glucose tolerance, metabolic syndrome);
  • Compromised immune system;
  • Pregnancy, menopause, or lactation;
  • Ongoing drug therapy that might affect the clinical characteristics of periodontitis and lipid metabolism;
  • Dental treatment during the 6 months prior to data collection.

Trial design

39 participants in 6 patient groups

Group 1-Health periodontal
Description:
This group created by individuals with healthy periodontal tissues. Periodontal status/peri-implant was assessed by clinical examination and classified according to criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions.
Treatment:
Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection
Group 2- Healthy peri-implant
Description:
This group created by individuals with healthy peri-implant tissues. Periodontal status/peri-implant was assessed by clinical examination and classified according to criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions.
Treatment:
Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection
group 3- Gingivitis
Description:
This group created by individuals with gingivitis. Periodontal/peri-implant status was assessed by clinical examination and classified according to criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions.
Treatment:
Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection
Group 4-Peri-implant Mucositis
Description:
This group created by individuals with peri-implant mucositis. Periodontal/peri-implant status was assessed by clinical examination and classified according to criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions.
Treatment:
Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection
Group 5-Periodontitis
Description:
This group created by individuals with periodontitis. Periodontal/peri-implant status was assessed by clinical examination and classified according to criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions.
Treatment:
Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection
Group 6-Periimplantitis
Description:
This group created by individuals with peri-implantitis. Periodontal/peri-implant status was assessed by clinical examination and classified according to criteria proposed by the 1999 International World Workshop for a Classification of Periodontal Disease and Conditions.
Treatment:
Diagnostic Test: gingival crevicular fluid (GCF) and peri-implant sulcular fluid(PISF) collection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems